RX-101

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRX-101
Drug Alias NameRX-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSuzhou Neupharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Neupharma Co Ltd
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A